Current status of theranostics in prostate cancer von Virgolini, Irene, Decristoforo, Clemens, Haug, Alexander, Fanti, Stefano, Uprimny, Christian

Volltext

Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy von Gabriel, Michael, Nilica, Bernhard, Kaiser, Bernhard, Virgolini, Irene J

Volltext

Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review von von Eyben, Finn Edler, Roviello, Giandomenico, Kiljunen, Timo, Uprimny, Christian, Virgolini, Irene, Kairemo, Kalevi, Joensuu, Timo

Volltext

(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? von Ceci, Francesco, Uprimny, Christian, Nilica, Bernhard, Geraldo, Llanos, Kendler, Dorota, Kroiss, Alexander, Bektic, Jasmin, Horninger, Wolfgang, Lukas, Peter, Decristoforo, Clemens, Castellucci, Paolo, Fanti, Stefano, Virgolini, Irene J

Volltext

Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer von von Guggenberg, Elisabeth, Uprimny, Christian, Klinger, Maximilian, Warwitz, Boris, Sviridenko, Anna, Bayerschmidt, Steffen, Santo, Gianpaolo di, Virgolini, Irene J

Volltext

Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (t... von Ahmadzadehfar, Hojjat, Rahbar, Kambiz, Baum, Richard P., Seifert, Robert, Kessel, Katharina, Bögemann, Martin, Kulkarni, Harshad R, Zhang, Jingjing, Gerke, Carolin, Fimmers, Rolf, Kratochwil, Clemens, Rathke, Hendrik, Ilhan, Harun, Maffey-Steffan, Johanna, Sathekge, Mike, Kabasakal, Levent, Garcia-Perez, Francisco Osvaldo, Kairemo, Kalevi, Maharaj, Masha, Paez, Diana, Virgolini, Irene

Volltext

Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the 68 Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer von von Guggenberg, Elisabeth, Uprimny, Christian, Klinger, Maximilian, Warwitz, Boris, Sviridenko, Anna, Bayerschmidt, Steffen, di Santo, Gianpaolo, Virgolini, Irene J

Volltext

European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma... von Taïeb, David, Hicks, Rodney J., Hindié, Elif, Guillet, Benjamin A., Avram, Anca, Ghedini, Pietro, Timmers, Henri J., Scott, Aaron T., Elojeimy, Saeed, Rubello, Domenico, Virgolini, Irène J., Fanti, Stefano, Balogova, Sona, Pandit-Taskar, Neeta, Pacak, Karel

Volltext

[68Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis von Haubner, Roland, Finkenstedt, Armin, Stegmayr, Armin, Rangger, Christine, Decristoforo, Clemens, Zoller, Heinz, Virgolini, Irene J.

Volltext

Overall survival results from the NETTER-1 trial in neuroendocrine tumours: an important milestone von Virgolini, Irene

Volltext

The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study von Ahmadzadehfar, Hojjat, Matern, Ralf, Baum, Richard P., Seifert, Robert, Kessel, Katharina, Bögemann, Martin, Kratochwil, Clemens, Rathke, Hendrik, Ilhan, Harun, Svirydenka, Hanna, Sathekge, Mike, Kabasakal, Levent, Yordanova, Anna, Garcia-Perez, Francisco Osvaldo, Kairemo, Kalevi, Maharaj, Masha, Paez, Diana, Virgolini, Irene, Rahbar, Kambiz

Volltext

Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use von Hodolic, Marina, Wu, Wen-Yu, Zhao, Zhenyu, Yu, Fei, Virgolini, Irene, Wang, Feng

Volltext

[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma von Hutterer, Markus, Nowosielski, Martha, Putzer, Daniel, Jansen, Nathalie L, Seiz, Marcel, Schocke, Michael, McCoy, Mark, Göbel, Georg, la Fougère, Christian, Virgolini, Irene J, Trinka, Eugen, Jacobs, Andreas H, Stockhammer, Günther

Volltext

High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma von Jha, Abhishek, Taïeb, David, Carrasquillo, Jorge A., Pryma, Daniel A., Patel, Mayank, Millo, Corina, de Herder, Wouter W., Del Rivero, Jaydira, Crona, Joakim, Shulkin, Barry L., Virgolini, Irene, Chen, Alice P., Mittal, Bhagwant R., Basu, Sandip, Dillon, Joseph S., Hope, Thomas A., Mari Aparici, Carina, Iagaru, Andrei H., Hicks, Rodney J., Avram, Anca M., Strosberg, Jonathan R., Civelek, Ali Cahid, Lin, Frank I., Pandit-Taskar, Neeta, Pacak, Karel

Volltext

Left hemispheric predominance of nigrostriatal dysfunction in Parkinson's disease von SCHERFLER, Christoph, SEPPI, Klaus, MAIR, Katherina J, DONNEMILLER, Eveline, VIRGOLINI, Irene, WENNING, Gregor K, POEWE, Werner

Volltext

O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma von Hutterer, Markus, Nowosielski, Martha, Putzer, Daniel, Waitz, Dietmar, Tinkhauser, Gerd, Kostron, Herwig, Muigg, Armin, Virgolini, Irene J, Staffen, Wolfgang, Trinka, Eugen, Gotwald, Thaddäus, Jacobs, Andreas H, Stockhammer, Guenther

Volltext

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions von Fanti, Stefano, Minozzi, Silvia, Morigi, Joshua James, Giesel, Frederik, Ceci, Francesco, Uprimny, Christian, Hofman, Michael S., Eiber, Matthias, Schwarzenbock, Sarah, Castellucci, Paolo, Bellisario, Cristina, Chauvie, Stéphane, Bergesio, Fabrizio, Emmett, Louise, Haberkorn, Uwe, Virgolini, Irene, Schwaiger, Markus, Hicks, Rodney J., Krause, Bernd J., Chiti, Arturo

Volltext

Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy von Mair, Christian, Warwitz, Boris, Fink, Katharina, Scarpa, Lorenza, Nilica, Bernhard, Maffey-Steffan, Johanna, Buxbaum, Sabine, Virgolini, Irene J.

Volltext

(68)Ga-PSMA ligand PET versus (18)F-NaF PET: evaluation of response to (223)Ra therapy in a prostate cancer patient von Uprimny, Christian, Kroiss, Alexander, Nilica, Bernhard, Buxbaum, Sabine, Decristoforo, Clemens, Horninger, Wolfgang, Virgolini, Irene J

Volltext

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review von Heidegger, Isabel, Kesch, Claudia, Kretschmer, Alexander, Tsaur, Igor, Ceci, Francesco, Valerio, Massimo, Tilki, Derya, Marra, Giancarlo, Preisser, Felix, Fankhauser, Christian D., Zattoni, Fabio, Chiu, Peter, Puche-Sanz, Ignacio, Olivier, Jonathan, van den Bergh, Roderik C. N., Kasivisvanathan, Veeru, Pircher, Andreas, Virgolini, Irene, Gandaglia, Giorgio

Volltext